vs
Side-by-side financial comparison of Clearfield, Inc. (CLFD) and ImmunityBio, Inc. (IBRX). Click either name above to swap in a different company.
ImmunityBio, Inc. is the larger business by last-quarter revenue ($38.3M vs $34.3M, roughly 1.1× Clearfield, Inc.). Clearfield, Inc. runs the higher net margin — -1.8% vs -161.8%, a 160.0% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs -3.2%). Clearfield, Inc. produced more free cash flow last quarter ($-2.4M vs $-71.3M).
Clearfield, Inc. is a company headquartered in Minneapolis, Minnesota. The company produces fiber optic products.
ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.
CLFD vs IBRX — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $34.3M | $38.3M |
| Net Profit | $-614.0K | $-61.9M |
| Gross Margin | 33.2% | 99.0% |
| Operating Margin | -5.3% | -169.0% |
| Net Margin | -1.8% | -161.8% |
| Revenue YoY | -3.2% | 407.0% |
| Net Profit YoY | 67.8% | -4.7% |
| EPS (diluted) | $-0.04 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $34.3M | $38.3M | ||
| Q3 25 | $23.4M | $32.1M | ||
| Q2 25 | $49.9M | $26.4M | ||
| Q1 25 | $47.2M | $16.5M | ||
| Q4 24 | $29.7M | $7.6M | ||
| Q3 24 | $5.6M | $6.1M | ||
| Q2 24 | $48.8M | — | ||
| Q1 24 | $36.9M | — |
| Q4 25 | $-614.0K | $-61.9M | ||
| Q3 25 | $-9.1M | $-67.3M | ||
| Q2 25 | $1.6M | $-92.6M | ||
| Q1 25 | $1.3M | $-129.6M | ||
| Q4 24 | $-1.9M | $-59.2M | ||
| Q3 24 | — | $-85.7M | ||
| Q2 24 | $-447.0K | — | ||
| Q1 24 | $-5.9M | — |
| Q4 25 | 33.2% | 99.0% | ||
| Q3 25 | 53.2% | 99.4% | ||
| Q2 25 | 30.5% | 99.5% | ||
| Q1 25 | 30.1% | 99.6% | ||
| Q4 24 | 29.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 21.9% | — | ||
| Q1 24 | 7.7% | — |
| Q4 25 | -5.3% | -169.0% | ||
| Q3 25 | 10.3% | -173.5% | ||
| Q2 25 | 3.0% | -269.8% | ||
| Q1 25 | 0.6% | -390.1% | ||
| Q4 24 | -6.9% | -919.0% | ||
| Q3 24 | — | -1314.3% | ||
| Q2 24 | -4.7% | — | ||
| Q1 24 | -26.4% | — |
| Q4 25 | -1.8% | -161.8% | ||
| Q3 25 | -38.8% | -209.8% | ||
| Q2 25 | 3.2% | -350.3% | ||
| Q1 25 | 2.8% | -784.9% | ||
| Q4 24 | -6.4% | -783.4% | ||
| Q3 24 | — | -1404.0% | ||
| Q2 24 | -0.9% | — | ||
| Q1 24 | -16.0% | — |
| Q4 25 | $-0.04 | $-0.06 | ||
| Q3 25 | $-0.65 | $-0.07 | ||
| Q2 25 | $0.11 | $-0.10 | ||
| Q1 25 | $0.09 | $-0.15 | ||
| Q4 24 | $-0.13 | $-0.08 | ||
| Q3 24 | — | $-0.14 | ||
| Q2 24 | $-0.04 | — | ||
| Q1 24 | $-0.40 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $96.4M | $242.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $249.7M | $-500.5M |
| Total Assets | $268.1M | $501.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $96.4M | $242.8M | ||
| Q3 25 | $106.0M | $257.8M | ||
| Q2 25 | $117.2M | $153.7M | ||
| Q1 25 | $112.0M | $61.6M | ||
| Q4 24 | $113.0M | $149.8M | ||
| Q3 24 | $129.0M | $130.4M | ||
| Q2 24 | $123.8M | — | ||
| Q1 24 | $142.9M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $2.2M | — | ||
| Q2 24 | $2.1M | — | ||
| Q1 24 | — | — |
| Q4 25 | $249.7M | $-500.5M | ||
| Q3 25 | $256.2M | $-524.3M | ||
| Q2 25 | $264.5M | $-570.7M | ||
| Q1 25 | $265.9M | $-591.4M | ||
| Q4 24 | $267.4M | $-489.1M | ||
| Q3 24 | $275.8M | $-745.1M | ||
| Q2 24 | $274.6M | — | ||
| Q1 24 | $279.2M | — |
| Q4 25 | $268.1M | $501.9M | ||
| Q3 25 | $306.2M | $519.0M | ||
| Q2 25 | $314.7M | $402.1M | ||
| Q1 25 | $310.9M | $303.8M | ||
| Q4 24 | $303.2M | $382.9M | ||
| Q3 24 | $315.3M | $364.6M | ||
| Q2 24 | $318.1M | — | ||
| Q1 24 | $315.4M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.01× | — | ||
| Q2 24 | 0.01× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.4M | $-70.4M |
| Free Cash FlowOCF − Capex | $-2.4M | $-71.3M |
| FCF MarginFCF / Revenue | -7.1% | -186.2% |
| Capex IntensityCapex / Revenue | 2.9% | 2.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-308.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.4M | $-70.4M | ||
| Q3 25 | — | $-68.9M | ||
| Q2 25 | $7.9M | $-79.7M | ||
| Q1 25 | $3.0M | $-85.9M | ||
| Q4 24 | $7.2M | $-85.1M | ||
| Q3 24 | $22.2M | $-98.8M | ||
| Q2 24 | $4.0M | — | ||
| Q1 24 | $-5.7M | — |
| Q4 25 | $-2.4M | $-71.3M | ||
| Q3 25 | — | $-69.6M | ||
| Q2 25 | $7.5M | $-80.8M | ||
| Q1 25 | $654.0K | $-87.0M | ||
| Q4 24 | $5.1M | $-87.3M | ||
| Q3 24 | $18.2M | $-101.6M | ||
| Q2 24 | $2.8M | — | ||
| Q1 24 | $-7.7M | — |
| Q4 25 | -7.1% | -186.2% | ||
| Q3 25 | — | -217.2% | ||
| Q2 25 | 15.1% | -305.9% | ||
| Q1 25 | 1.4% | -526.9% | ||
| Q4 24 | 17.1% | -1155.4% | ||
| Q3 24 | 323.0% | -1663.2% | ||
| Q2 24 | 5.8% | — | ||
| Q1 24 | -20.8% | — |
| Q4 25 | 2.9% | 2.4% | ||
| Q3 25 | 2.0% | 2.3% | ||
| Q2 25 | 0.8% | 4.1% | ||
| Q1 25 | 5.1% | 6.8% | ||
| Q4 24 | 7.0% | 28.0% | ||
| Q3 24 | 71.4% | 45.7% | ||
| Q2 24 | 2.5% | — | ||
| Q1 24 | 5.3% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 4.93× | — | ||
| Q1 25 | 2.30× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
